- Home
- IMPP vs OSUR Comparison
IMPP vs OSUR Comparison
Compare IMPP & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMPP | OSUR |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.7M | 247.6M |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IMPP | OSUR |
|---|---|---|
| Price | $5.31 | $3.61 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 358.1K | ★ 436.5K |
| Earning Date | 05-22-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $51.79 | $4.48 |
| Revenue Next Year | $6.97 | $7.76 |
| P/E Ratio | $3.68 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.15 | $2.08 |
| 52 Week High | $6.57 | $4.58 |
Technical Indicators
Market Signals| Indicator | IMPP | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 41.26 |
| Support Level | $4.64 | $2.86 |
| Resistance Level | $5.30 | $3.93 |
| Average True Range (ATR) | 0.22 | 0.13 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 76.67 | 25.00 |
Price Performance
Historical ComparisonAbout IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.